{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T03:50:48Z","timestamp":1780113048729,"version":"3.54.0"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2022,7,20]],"date-time":"2022-07-20T00:00:00Z","timestamp":1658275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,7,20]],"date-time":"2022-07-20T00:00:00Z","timestamp":1658275200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100018998","name":"Ege University Research Foundation","doi-asserted-by":"publisher","award":["17-TIP-004"],"award-info":[{"award-number":["17-TIP-004"]}],"id":[{"id":"10.13039\/501100018998","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Parasit."],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1007\/s11686-022-00594-6","type":"journal-article","created":{"date-parts":[[2022,7,20]],"date-time":"2022-07-20T06:02:57Z","timestamp":1658296977000},"page":"1354-1363","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["The Designing of a Gel Formulation with Chitosan Polymer Using Liposomes as Nanocarriers of Amphotericin B for a Non-invasive Treatment Model of Cutaneous Leishmaniasis"],"prefix":"10.1007","volume":"67","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1100-910X","authenticated-orcid":false,"given":"Nergiz","family":"G\u00dcRB\u00dcZ \u00c7OLAK","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8822-9130","authenticated-orcid":false,"given":"Emel \u00d6yk\u00fc","family":"\u00c7ET\u0130N UYANIKG\u0130L","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8335-1997","authenticated-orcid":false,"given":"Yusuf","family":"\u00d6ZBEL","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5957-8665","authenticated-orcid":false,"given":"Seray","family":"T\u00d6Z","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,7,20]]},"reference":[{"key":"594_CR1","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1590\/0037-8682-0041-2016","volume":"158","author":"PP Bose","year":"2016","unstructured":"Bose PP, Kumar P, Dwivedi MK (2016) Hemoglobin guided nanocarrier for specific delivery of Amphotericin B to Leishmania infected macrophage. Acta Trop 158:148\u2013159. https:\/\/doi.org\/10.1590\/0037-8682-0041-2016","journal-title":"Acta Trop"},{"key":"594_CR2","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1007\/s13346-020-00806-4","volume":"10","author":"S \u015eenel","year":"2020","unstructured":"\u015eenel S, Y\u00fcksel S (2020) Chitosan-based particulate systems for drug and vaccine delivery in the treatment and prevention of neglected tropical diseases. Drug Deliv Transl Res 10:1644\u20131674. https:\/\/doi.org\/10.1007\/s13346-020-00806-4","journal-title":"Drug Deliv Transl Res"},{"key":"594_CR3","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.jddst.2018.12.031","volume":"50","author":"S Malli","year":"2019","unstructured":"Malli S, Pomel S, Dennemont I, Loiseau PM, Bouchemal K (2019) Combination of Amphotericin B and chitosan platelets for the treatment of experimental cutaneous leishmaniasis: histological and immunohistochemical examinations. J Drug Deliv Sci Technol 50:34\u201341. https:\/\/doi.org\/10.1016\/j.jddst.2018.12.031","journal-title":"J Drug Deliv Sci Technol"},{"key":"594_CR4","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.ijbiomac.2020.06.240","volume":"15","author":"M Alishahi","year":"2020","unstructured":"Alishahi M, Khorram M, Asgari Q, Davani F, Goudarzi F, Emami A, Arastehfar A, Zomorodian K (2020) Glucantime-loaded electrospun core-shell nanofibers composed of poly(ethylene oxide)\/gelatin-poly(vinyl alcohol)\/chitosan as dressing for cutaneous leishmaniasis. Int J Biol Macromol 15:288\u2013297. https:\/\/doi.org\/10.1016\/j.ijbiomac.2020.06.240","journal-title":"Int J Biol Macromol"},{"key":"594_CR5","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1590\/0037-8682-0138-2015","volume":"48","author":"MA Ch\u00e1vez-Fumagalli","year":"2015","unstructured":"Ch\u00e1vez-Fumagalli MA, Ribeiro TG, Castilho RO, Fernandes SO, Cardoso VN, Coelho CS, Mendon\u00e7a DV, Soto M, Tavares CA, Faraco AA, Coelho EA (2015) New delivery systems for Amphotericin B applied to the improvement of leishmaniasis treatment. Rev Soc Bras Med Trop 48:235\u2013242. https:\/\/doi.org\/10.1590\/0037-8682-0138-2015","journal-title":"Rev Soc Bras Med Trop"},{"key":"594_CR6","doi-asserted-by":"publisher","first-page":"877","DOI":"10.2147\/IJN.S55678","volume":"9","author":"TG Ribeiro","year":"2014","unstructured":"Ribeiro TG, Ch\u00e1vez-Fumagalli MA, Valadares DG, Fran\u00e7a JR, Rodrigues LB, Duarte DC, Lage PS, Andrade PH, Lage DP, Arruda LV, Ab\u00e1nades DR, Costa LE, Martins VT, Tavares CA, Castilho RH, Coelho EA, Faraco AA (2014) Novel targeting using nanoparticles: an approach to the development of an effective anti-leishmanial drug-delivery system. Int J Nanomedicine 9:877\u2013890. https:\/\/doi.org\/10.2147\/IJN.S55678","journal-title":"Int J Nanomedicine"},{"key":"594_CR7","doi-asserted-by":"publisher","first-page":"4617","DOI":"10.1007\/s00436-015-4707-5","volume":"114","author":"S Bahrami","year":"2015","unstructured":"Bahrami S, Esmaeilzadeh S, Zarei M, Ahmadi F (2015) Potential application of nanochitosan film as a therapeutic agent against cutaneous leishmaniasis caused by L. major. Parasitol Res 114:4617\u20134624. https:\/\/doi.org\/10.1007\/s00436-015-4707-5","journal-title":"Parasitol Res"},{"key":"594_CR8","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.exppara.2018.07.003","volume":"192","author":"DM Casa","year":"2018","unstructured":"Casa DM, Scariot DB, Khalil NM, Nakamura CV, Mainardes RM (2018) Bovine serum albumin nanoparticles containing Amphotericin B were effective in treating murine cutaneous leishmaniasis and reduced the drug toxicity. Exp Parasitol 192:12\u201318. https:\/\/doi.org\/10.1016\/j.exppara.2018.07.003","journal-title":"Exp Parasitol"},{"key":"594_CR9","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.ajme.2018.06.002","volume":"54","author":"NAD Atan","year":"2018","unstructured":"Atan NAD, Koushki M, Ahmadi NA, Rezaei-Tavirani M (2018) Metabolomics-based studies in the field of Leishmania\/leishmaniasis. Alex J Med 54:383\u2013390. https:\/\/doi.org\/10.1016\/j.ajme.2018.06.002","journal-title":"Alex J Med"},{"key":"594_CR10","doi-asserted-by":"publisher","first-page":"111","DOI":"10.4103\/0972-9062.242557","volume":"55","author":"BR Esboei","year":"2018","unstructured":"Esboei BR, Mohebali M, Mousavi P, Fakhar M, Akhoundi B (2018) Potent antileishmanial activity of chitosan against Iranian strain of Leishmania major (MRHO\/IR\/75\/ER): In vitro and in vivo assay. J Vector Borne Dis 55:111\u2013115. https:\/\/doi.org\/10.4103\/0972-9062.242557","journal-title":"J Vector Borne Dis"},{"key":"594_CR11","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1007\/s12639-014-0637-x","volume":"40","author":"M Khosravani","year":"2016","unstructured":"Khosravani M, Moemenbellah-Fard MD, Sharafi M, Rafat-Panah A (2016) Epidemiologic profile of oriental sore caused by Leishmania parasites in a new endemic focus of cutaneous leishmaniasis, Southern Iran. J Parasit Dis 40:1077\u20131081. https:\/\/doi.org\/10.1007\/s12639-014-0637-x","journal-title":"J Parasit Dis"},{"key":"594_CR12","doi-asserted-by":"publisher","first-page":"2669","DOI":"10.1007\/s00436-019-06382-y","volume":"118","author":"S Mohtasebi","year":"2019","unstructured":"Mohtasebi S, Mohebali M, Elikaee S, Akhoundi B, Foroushani AR, Teimouri A, Yarizadeh H (2019) In vitro and in vivo anti-parasitic activity of biogenic antimony sulfide nanoparticles on Leishmania major (MRHO\/IR\/75\/ER). Parasitol Res 118:2669\u20132678. https:\/\/doi.org\/10.1007\/s00436-019-06382-y","journal-title":"Parasitol Res"},{"key":"594_CR13","unstructured":"CDCP, Centers for Disease Control and Prevention, Available online: https:\/\/www.cdc.gov\/parasites\/leishmaniasis\/ (accessed January 2022)"},{"key":"594_CR14","doi-asserted-by":"publisher","first-page":"2573","DOI":"10.1021\/acsabm.9b00263","volume":"2","author":"S Malli","year":"2019","unstructured":"Malli S, Pomel S, Ayadi Y, Delom\u00e9nie C, Da Costa A, Loiseau PM, Bouchemal K (2019) Topically applied chitosan-coated poly(isobutylcyanoacrylate) nanoparticles are active against cutaneous leishmaniasis by accelerating lesion healing and reducing the parasitic load. ACS Appl Bio Mater 2:2573\u20132586. https:\/\/doi.org\/10.1021\/acsabm.9b00263","journal-title":"ACS Appl Bio Mater"},{"key":"594_CR15","doi-asserted-by":"publisher","first-page":"7593","DOI":"10.2147\/IJN.S220410","volume":"14","author":"T Zadeh Mehrizi","year":"2019","unstructured":"Zadeh Mehrizi T, Khamesipour A, Shafiee Ardestani M, Ebrahimi Shahmabadi H, Haji Molla Hoseini M, Mosaffa N, Ramezani A (2019) Comparative analysis between four model nanoformulations of Amphotericin B-chitosan, Amphotericin B-dendrimer, betulinic acid-chitosan and betulinic acid-dendrimer for treatment of Leishmania major: Real-time PCR assay plus. Int J Nanomedicine 14:7593\u20137607. https:\/\/doi.org\/10.2147\/IJN.S220410","journal-title":"Int J Nanomedicine"},{"key":"594_CR16","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1093\/mmy\/myv111","volume":"54","author":"JP Adler-Moore","year":"2016","unstructured":"Adler-Moore JP, Gangneux JP, Pappas PG (2016) Comparison between liposomal formulations of Amphotericin B. Med Mycol 54:223\u2013231. https:\/\/doi.org\/10.1093\/mmy\/myv111","journal-title":"Med Mycol"},{"key":"594_CR17","doi-asserted-by":"publisher","first-page":"25","DOI":"10.2147\/DDDT.S146521","volume":"12","author":"M Ghorbani","year":"2017","unstructured":"Ghorbani M, Farhoudi R (2017) Leishmaniasis in humans: drug or vaccine therapy? Drug Des Devel Ther 12:25\u201340. https:\/\/doi.org\/10.2147\/DDDT.S146521","journal-title":"Drug Des Devel Ther"},{"key":"594_CR18","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1590\/0037-8682-0041-2016","volume":"49","author":"SE Borborema","year":"2016","unstructured":"Borborema SE, Osso Junior JA, Andrade Junior HF, Nascimento N (2016) Antimonial drugs entrapped into phosphatidylserine liposomes: physicochemical evaluation and antileishmanial activity. Rev Soc Bras Med Trop 49:196\u2013203. https:\/\/doi.org\/10.1590\/0037-8682-0041-2016","journal-title":"Rev Soc Bras Med Trop"},{"key":"594_CR19","doi-asserted-by":"publisher","first-page":"2123","DOI":"10.1002\/jctb.6633","volume":"96","author":"SSC Oliveira","year":"2021","unstructured":"Oliveira SSC, Ferreira CS, Branquinha MH, Santos ALS, Chaud MV, Jain S, Cardoso JC, Kova\u010devi\u0107 AB, Souto EB, Severino P (2021) Overcoming multi-resistant Leishmania treatment by nanoencapsulation of potent antimicrobials. J Chem Technol Biotechnol 96:2123\u20132140. https:\/\/doi.org\/10.1002\/jctb.6633","journal-title":"J Chem Technol Biotechnol"},{"key":"594_CR20","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.3390\/ma11071167","volume":"11","author":"E Palma","year":"2018","unstructured":"Palma E, Pasqua A, Gagliardi A, Britti D, Fresta M, Cosco D (2018) Antileishmanial activity of Amphotericin B-loaded-PLGA nanoparticles: an overview. Materials (Basel) 11:1167. https:\/\/doi.org\/10.3390\/ma11071167","journal-title":"Materials (Basel)"},{"key":"594_CR21","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2020.570573","volume":"10","author":"S Parvez","year":"2020","unstructured":"Parvez S, Yadagiri G, Karole A, Singh OP, Verma A, Sundar S, Mudavath SL (2020) Recuperating biopharmaceutical aspects of Amphotericin B and Paromomycin using a chitosan functionalized nanocarrier via oral route for enhanced anti-leishmanial activity. Front Cell Infect Microbiol 10:570573. https:\/\/doi.org\/10.3389\/fcimb.2020.570573","journal-title":"Front Cell Infect Microbiol"},{"key":"594_CR22","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.jchromb.2016.06.008","volume":"1028","author":"C Ran","year":"2016","unstructured":"Ran C, Chen D, Xu M, Du C, Li Q, Jiang Y (2016) A study on characteristic of different sample pretreatment methods to evaluate the entrapment efficiency of liposomes. J Chromatogr B Analyt Technol Biomed Life Sci 1028:56\u201362. https:\/\/doi.org\/10.1016\/j.jchromb.2016.06.008","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"594_CR23","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.exppara.2014.04.013","volume":"143","author":"SA Moosavian Kalat","year":"2014","unstructured":"Moosavian Kalat SA, Khamesipour A, Bavarsad N, Fallah M, Khashayarmanesh Z, Feizi E, Neghabi K, Abbasi A, Jaafari MR (2014) Use of topical liposomes containing meglumine antimoniate (Glucantime) for the treatment of L. major lesion in BALB\/c mice. Exp Parasitol 143:5\u201310. https:\/\/doi.org\/10.1016\/j.exppara.2014.04.013","journal-title":"Exp Parasitol"},{"key":"594_CR24","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.biotechadv.2011.05.009","volume":"30","author":"F Akhtar","year":"2012","unstructured":"Akhtar F, Rizvi MM, Kar SK (2012) Oral delivery of curcumin bound to chitosan nanoparticles cured Plasmodium yoelii infected mice. Biotechnol Adv 30:310\u2013320. https:\/\/doi.org\/10.1016\/j.biotechadv.2011.05.009","journal-title":"Biotechnol Adv"},{"key":"594_CR25","doi-asserted-by":"publisher","first-page":"5114","DOI":"10.3390\/molecules25215114","volume":"25","author":"WH Lo","year":"2020","unstructured":"Lo WH, Deng FS, Chang CJ, Lin CH (2020) Synergistic antifungal activity of chitosan with fluconazole against Candida albicans, Candida tropicalis, and fluconazole-resistant strains. Molecules 25:5114. https:\/\/doi.org\/10.3390\/molecules25215114","journal-title":"Molecules"},{"key":"594_CR26","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.ijbiomac.2020.03.148","volume":"154","author":"X Lang","year":"2020","unstructured":"Lang X, Wang T, Sun M, Chen X, Liu Y (2020) Advances and applications of chitosan-based nanomaterials as oral delivery carriers: a review. Int J Biol Macromol 154:433\u2013445. https:\/\/doi.org\/10.1016\/j.ijbiomac.2020.03.148","journal-title":"Int J Biol Macromol"},{"key":"594_CR27","doi-asserted-by":"publisher","first-page":"4123","DOI":"10.3390\/molecules25184123","volume":"25","author":"PM Loiseau","year":"2020","unstructured":"Loiseau PM, Pomel S, Croft SL (2020) Chitosan contribution to therapeutic and vaccinal approaches for the control of Leishmaniasis. Molecules 25:4123. https:\/\/doi.org\/10.3390\/molecules25184123","journal-title":"Molecules"},{"key":"594_CR28","first-page":"22","volume":"949","author":"World Health Organization","year":"2010","unstructured":"World Health Organization (2010) Control of the leishmaniases. Tech Report 949:22\u201326","journal-title":"Tech Report"},{"key":"594_CR29","doi-asserted-by":"publisher","first-page":"56","DOI":"10.3390\/pharmaceutics9040056","volume":"9","author":"T Mengoni","year":"2017","unstructured":"Mengoni T, Adrian M, Pereira S, Santos-Carballal B, Kaiser M, Goycoolea FM (2017) A chitosan-based liposome formulation enhances the in vitro wound healing efficacy of substance P neuropeptide. Pharmaceutics 9:56. https:\/\/doi.org\/10.3390\/pharmaceutics9040056","journal-title":"Pharmaceutics"},{"key":"594_CR30","doi-asserted-by":"publisher","first-page":"10020","DOI":"10.1021\/la9008834","volume":"25","author":"Y Fukui","year":"2009","unstructured":"Fukui Y, Fujimoto K (2009) The preparation of sugar polymer-coated nanocapsules by the layer-by-layer deposition on the liposome. Langmuir 25:10020\u201310025. https:\/\/doi.org\/10.1021\/la9008834","journal-title":"Langmuir"},{"key":"594_CR31","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.colsurfb.2015.12.003","volume":"139","author":"AP Perez","year":"2016","unstructured":"Perez AP, Altube MJ, Schilrreff P, Apezteguia G, Celes FS, Zacchino S, de Oliveira CI, Romero EL, Morilla MJ (2016) Topical Amphotericin B in ultradeformable liposomes: Formulation, skin penetration study, antifungal and antileishmanial activity in vitro. Colloids Surf B Biointerfaces 139:190\u2013198. https:\/\/doi.org\/10.1016\/j.colsurfb.2015.12.003","journal-title":"Colloids Surf B Biointerfaces"},{"key":"594_CR32","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.1208\/s12248-017-0142-0","volume":"19","author":"D Solomon","year":"2017","unstructured":"Solomon D, Gupta N, Mulla NS, Shukla S, Guerrero YA, Gupta V (2017) Role of in vitro release methods in liposomal formulation development: challenges and regulatory perspective. AAPS J 19:1669\u20131681. https:\/\/doi.org\/10.1208\/s12248-017-0142-0","journal-title":"AAPS J"},{"key":"594_CR33","unstructured":"\u00c7etin E\u00d6 (2008). Peridontal hastal\u0131klar\u0131n tedavisinde kullan\u0131lan lokal kontroll\u00fc sal\u0131m sistemlerinin incelenmesi. Ege University, PhD Dissertation"},{"key":"594_CR34","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.jcis.2017.08.011","volume":"507","author":"A Froelich","year":"2017","unstructured":"Froelich A, Osma\u0142ek T, Snela A, Kunstman P, Jadach B, Olejniczak M, Roszak G, Bia\u0142as W (2017) Novel microemulsion-based gels for topical delivery of indomethacin: formulation, physicochemical properties and in vitro drug release studies. J Colloid Interface Sci 507:323\u2013336. https:\/\/doi.org\/10.1016\/j.jcis.2017.08.011","journal-title":"J Colloid Interface Sci"},{"key":"594_CR35","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1111\/ijd.14002","volume":"57","author":"S Uzun","year":"2018","unstructured":"Uzun S, G\u00fcrel MS, Durdu M, Akyol M, Fettahl\u0131o\u011flu Karaman B, Aksoy M et al (2018) Clinical practice guidelines for the diagnosis and treatment of cutaneous leishmaniasis in Turkey. Int J Dermatol 57:973\u2013982. https:\/\/doi.org\/10.1111\/ijd.14002","journal-title":"Int J Dermatol"},{"key":"594_CR36","doi-asserted-by":"publisher","first-page":"121","DOI":"10.5152\/tpd.2012.29","volume":"36","author":"MS G\u00fcrel","year":"2012","unstructured":"G\u00fcrel MS, Ye\u015filova Y, \u00d6lgen MK, \u00d6zbel Y (2012) Cutaneous leishmaniasis in Turkey. Turkiye Parazitol Derg 36:121\u2013129. https:\/\/doi.org\/10.5152\/tpd.2012.29","journal-title":"Turkiye Parazitol Derg"},{"key":"594_CR37","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1080\/17425247.2019.1659243","volume":"16","author":"JS Lanza","year":"2019","unstructured":"Lanza JS, Pomel S, Loiseau PM, Fr\u00e9zard F (2019) Recent advances in Amphotericin B delivery strategies for the treatment of leishmaniases. Expert Opin Drug Deliv 16:1063\u20131079. https:\/\/doi.org\/10.1080\/17425247.2019.1659243","journal-title":"Expert Opin Drug Deliv"},{"key":"594_CR38","unstructured":"Kim J, De Jesus O, Medication routes of administration. [Updated 2021 Aug 30]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan-. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK568677\/"},{"key":"594_CR39","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1080\/08982104.2020.1749067","volume":"31","author":"J T\u00e9llez","year":"2021","unstructured":"T\u00e9llez J, Echeverry MC, Romero I, Guatibonza A, Santos Ramos G, Borges De Oliveira AC, Fr\u00e9zard F, Demicheli C (2021) Use of liposomal nanoformulations in antileishmania therapy: challenges and perspectives. J Liposome Res 31:169\u2013176. https:\/\/doi.org\/10.1080\/08982104.2020.1749067","journal-title":"J Liposome Res"},{"key":"594_CR40","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1080\/08982104.2017.1376682","volume":"27","author":"V Ortega","year":"2017","unstructured":"Ortega V, Giorgio S, de Paula E (2017) Liposomal formulations in the pharmacological treatment of leishmaniasis: a review. J Liposome Res 27:234\u2013248. https:\/\/doi.org\/10.1080\/08982104.2017.1376682","journal-title":"J Liposome Res"},{"key":"594_CR41","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.colsurfb.2015.08.037","volume":"136","author":"P Tripathi","year":"2015","unstructured":"Tripathi P, Dwivedi P, Khatik R, Jaiswal AK, Dube A, Shukla P, Mishra PR (2015) Development of 4-sulfated N-acetyl galactosamine anchored chitosan nanoparticles: a dual strategy for effective management of Leishmaniasis. Colloids Surf B Biointerfaces 136:150\u2013159. https:\/\/doi.org\/10.1016\/j.colsurfb.2015.08.037","journal-title":"Colloids Surf B Biointerfaces"},{"key":"594_CR42","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1080\/08982104.2016.1205087","volume":"27","author":"K Takemoto","year":"2017","unstructured":"Takemoto K, Kanazawa K (2017) Am Bisome: relationship between the pharmacokinetic characteristics acquired by liposomal formulation and safety\/efficacy. J Liposome Res 27:186\u2013194. https:\/\/doi.org\/10.1080\/08982104.2016.1205087","journal-title":"J Liposome Res"},{"key":"594_CR43","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1093\/jac\/49.suppl_1.21","volume":"1","author":"J Adler-Moore","year":"2002","unstructured":"Adler-Moore J, Proffitt RT (2002) Am Bisome: liposomal formulation, structure, mechanism of action and pre-clinical experience. J Antimicrob Chemother 1:21\u201330. https:\/\/doi.org\/10.1093\/jac\/49.suppl_1.21","journal-title":"J Antimicrob Chemother"},{"key":"594_CR44","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/6147315","author":"J Baranauskaite","year":"2018","unstructured":"Baranauskaite J, Duman G, Corapc\u0131o\u011flu G, Baranauskas A, Taralp A, Ivanauskas L, Bernatoniene J (2018) Liposomal incorporation to improve dissolution and stability of rosmarinic acid and carvacrol extracted from oregano (O. onites L). Biomed Res Int. https:\/\/doi.org\/10.1155\/2018\/6147315","journal-title":"Biomed Res Int"},{"key":"594_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2020.101944","volume":"60","author":"A Mishra","year":"2020","unstructured":"Mishra A, Bano M, Bisen AC, Verma S, Sanap SN, Kishor R, Shukla PK, Bhatta RS (2020) Topical corneal targeted sustained release Amphotericin B liposomal formulation for the treatment of fungal keratitis and its PK-PD evaluation. J Drug Deliv Sci Technol 60:101944. https:\/\/doi.org\/10.1016\/j.jddst.2020.101944","journal-title":"J Drug Deliv Sci Technol"},{"key":"594_CR46","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.ejpb.2020.09.008","volume":"157","author":"Y Liu","year":"2020","unstructured":"Liu Y, Mei Z, Mei L, Tang J, Yuan W, Srinivasan S, Ackermann R, Schwendeman AS (2020) Analytical method development and comparability study for Am Bisome\u00ae and generic Amphotericin B liposomal products. Eur J Pharm Biopharm 157:241\u2013249. https:\/\/doi.org\/10.1016\/j.ejpb.2020.09.008","journal-title":"Eur J Pharm Biopharm"},{"key":"594_CR47","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1080\/08982104.2020.1755980","volume":"31","author":"NB Mutlu-Agardan","year":"2021","unstructured":"Mutlu-Agardan NB, Yilmaz S, Kaynak Onurdag F, Celebi N (2021) Development of effective AmB\/AmB-\u03b1CD complex double loaded liposomes using a factorial design for systemic fungal infection treatment. J Liposome Res 31:177\u2013188. https:\/\/doi.org\/10.1080\/08982104.2020.1755980","journal-title":"J Liposome Res"},{"key":"594_CR48","doi-asserted-by":"publisher","first-page":"3227","DOI":"10.1208\/s12249-017-0812-3","volume":"18","author":"A Wang","year":"2017","unstructured":"Wang A, Ahmad A, Ullah S, Cheng L, Ke L, Yuan Q (2017) A cheap and convenient method of liposome preparation using glass beads as a source of shear force. AAPS Pharm Sci Tech 18:3227\u20133235. https:\/\/doi.org\/10.1208\/s12249-017-0812-3","journal-title":"AAPS Pharm Sci Tech"},{"key":"594_CR49","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/j.ijbiomac.2020.02.166","volume":"152","author":"AR Richter","year":"2020","unstructured":"Richter AR, Carneiro MJ, de Sousa NA, Pinto VPT, Freire RS, de Sousa JS et al (2020) Self-assembling cashew gum-graft-polylactide copolymer nanoparticles as a potential Amphotericin B delivery matrix. Int J Biol Macromol 152:492\u2013502. https:\/\/doi.org\/10.1016\/j.ijbiomac.2020.02.166","journal-title":"Int J Biol Macromol"},{"key":"594_CR50","doi-asserted-by":"publisher","first-page":"134","DOI":"10.3109\/08982104.2012.762519","volume":"23","author":"A Momeni","year":"2013","unstructured":"Momeni A, Rasoolian M, Momeni A, Navaei A, Emami S, Shaker Z, Mohebali M, Khoshdel A (2013) Development of liposomes loaded with anti-leishmanial drugs for the treatment of cutaneous leishmaniasis. J Liposome Res 23:134\u2013144. https:\/\/doi.org\/10.3109\/08982104.2012.762519","journal-title":"J Liposome Res"},{"key":"594_CR51","doi-asserted-by":"publisher","first-page":"4","DOI":"10.4172\/2155-952X.1000276","volume":"7","author":"D Yadav","year":"2017","unstructured":"Yadav D, Sandeep K, Pandey D, Dutta RK (2017) Liposomes for drug delivery. J Biotechnol Biomater 7:4. https:\/\/doi.org\/10.4172\/2155-952X.1000276","journal-title":"J Biotechnol Biomater"},{"key":"594_CR52","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.apsb.2011.09.002","volume":"1","author":"GP Kumar","year":"2011","unstructured":"Kumar GP, Rajeshwarrao P (2011) Nonionic surfactant vesicular systems for effective drug delivery-an overview. Acta Pharm Sin 1:208\u2013219. https:\/\/doi.org\/10.1016\/j.apsb.2011.09.002","journal-title":"Acta Pharm Sin"},{"issue":"8","key":"594_CR53","doi-asserted-by":"publisher","first-page":"637","DOI":"10.3109\/10611861003649712","volume":"18","author":"JW Kang","year":"2010","unstructured":"Kang JW, Davaa E, Kim YT, Park JS (2010) A new vaginal delivery system of Amphotericin B: a dispersion of cationic liposome in a thermosensitive gel. J Drug Target 18(8):637\u2013644","journal-title":"J Drug Target"},{"key":"594_CR54","unstructured":"Silverman RB (2004). The organic chemistry of drug design and drug action (Second Edition), Elsevier Academic Press"},{"key":"594_CR55","first-page":"17","volume":"44","author":"G Tiwari","year":"2019","unstructured":"Tiwari G, Tiwari R, Wal P, Wal A (2019) Development and optimization of liposomes containing 5 fluorouracil and tretinoin for skin warts: 32 experimental design. FABAD J Pharm Sci 44:17\u201326","journal-title":"FABAD J Pharm Sci"},{"key":"594_CR56","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1590\/0074-02760160557","volume":"112","author":"LF Antonio","year":"2017","unstructured":"Antonio LF, Lyra MR, Saheki MN, Schubach AO, Miranda LFC, Madeira MF et al (2017) Effect of secondary infection on epithelialization and total healing of cutaneous leishmaniasis lesions. Mem Inst Oswaldo Cruz 112:640\u2013646. https:\/\/doi.org\/10.1590\/0074-02760160557","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"594_CR57","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1080\/10837450.2018.1425432","volume":"24","author":"B Siska","year":"2019","unstructured":"Siska B, Snejdrova E, Machac I, Dolecek P, Martiska J (2019) Contribution to the rheological testing of pharmaceutical semisolids. Pharm Dev Technol 24:80\u201388. https:\/\/doi.org\/10.1080\/10837450.2018.1425432","journal-title":"Pharm Dev Technol"},{"key":"594_CR58","doi-asserted-by":"publisher","first-page":"2663","DOI":"10.1007\/s11095-015-1651-0","volume":"32","author":"S Asthana","year":"2015","unstructured":"Asthana S, Gupta PK, Jaiswal AK, Dube A, Chourasia MK (2015) Overexpressed macrophage mannose receptor targeted nanocapsules- mediated cargo delivery approach for eradication of resident parasite: In vitro and in vivo studies. Pharm Res 32:2663\u20132677. https:\/\/doi.org\/10.1007\/s11095-015-1651-0","journal-title":"Pharm Res"},{"key":"594_CR59","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1021\/mp400603t","volume":"11","author":"PK Gupta","year":"2014","unstructured":"Gupta PK, Jaiswal AK, Kumar V, Verma A, Dwivedi P, Dube A, Mishra PR (2014) Covalent functionalized self-assembled lipo-polymerosome bearing amphotericin B for better management of leishmaniasis and its toxicity evaluation. Mol Pharm 11:951\u2013963. https:\/\/doi.org\/10.1021\/mp400603t","journal-title":"Mol Pharm"},{"key":"594_CR60","doi-asserted-by":"publisher","DOI":"10.1080\/00914037.2020.1785457","author":"MMS Messeder","year":"2021","unstructured":"Messeder MMS, Miranda D, Souza SOL, Dorneles M, Giunchetti R, Or\u00e9fice RL (2021) Positively-charged electrosprayed nanoparticles based on biodegradable polymers containing Amphotericin B for the treatment of leishmaniasis. Int J Polym Mater. https:\/\/doi.org\/10.1080\/00914037.2020.1785457","journal-title":"Int J Polym Mater"},{"key":"594_CR61","doi-asserted-by":"publisher","first-page":"71705","DOI":"10.1039\/C6RA06007B","volume":"6","author":"PK Singh","year":"2016","unstructured":"Singh PK, Sah P, Meher JG, Joshi S, Pawar VK, Raval K, Singh Y, Sharma K, Kumar A, Dube A, Chourasia MK (2016) Macrophage-targeted chitosan anchored PLGA nanoparticles bearing doxorubicin and Amphotericin B against visceral leishmaniasis. RSC Adv 6:71705. https:\/\/doi.org\/10.1039\/C6RA06007B","journal-title":"RSC Adv"},{"key":"594_CR62","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.ijbiomac.2017.08.177","volume":"107","author":"J Varshosaz","year":"2018","unstructured":"Varshosaz J, Arbabi B, Pestehchian N, Saberi S, Delavari M (2018) Chitosan-titanium dioxide-glucantime nanoassemblies effects on promastigote and amastigote of Leishmania major. Int J Biol Macromol 107:212\u2013221. https:\/\/doi.org\/10.1016\/j.ijbiomac.2017.08.177","journal-title":"Int J Biol Macromol"},{"key":"594_CR63","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1016\/j.ijbiomac.2017.07.161","volume":"105","author":"PK Singh","year":"2017","unstructured":"Singh PK, Pawar VK, Jaiswal AK, Singh Y, Srikanth CH, Chaurasia M, Bora HK, Raval K, Meher JG, Gayen JR, Dube A, Chourasia MK (2017) Chitosan coated PluronicF127 micelles for effective delivery of Amphotericin B in experimental visceral leishmaniasis. Int J Biol Macromol 105:1220\u20131231. https:\/\/doi.org\/10.1016\/j.ijbiomac.2017.07.161","journal-title":"Int J Biol Macromol"},{"key":"594_CR64","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1007\/s00436-008-0901-z","volume":"102","author":"G Pujals","year":"2008","unstructured":"Pujals G, Su\u00f1\u00e9-Negre JM, P\u00e9rez P, Garc\u00eda E, Portus M, Tico JR, Mi\u00f1arro M, Carri\u00f3 J (2008) In vitro evaluation of the effectiveness and cytotoxicity of meglumine antimoniate microspheres produced by spray drying against Leishmania infantum. Parasitol Res 102:1243\u20131247. https:\/\/doi.org\/10.1007\/s00436-008-0901-z","journal-title":"Parasitol Res"},{"key":"594_CR65","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1007\/s11095-014-1571-4","volume":"32","author":"PK Gupta","year":"2014","unstructured":"Gupta PK, Jaiswal AK, Asthana S, Vermac A, Kumar V, Shukla P, Dwivedi P, Dube A, Mishra PR (2014) Self-assembled ionically sodium alginate cross-linked Amphotericin B encapsulated glycol chitosan stearate nanoparticles: applicability in better chemotherapy and non-toxic delivery in visceral leishmaniasis. Pharm Res 32:1727\u20131740. https:\/\/doi.org\/10.1007\/s11095-014-1571-4","journal-title":"Pharm Res"},{"key":"594_CR66","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1007\/s12010-014-1084-y","volume":"174","author":"V Jain","year":"2014","unstructured":"Jain V, Gupta A, Pawar VK, Asthana S, Jaiswal AK, Dube A, Chourasia MK (2014) Chitosan-assisted immunotherapy for intervention of experimental leishmaniasis via Amphotericin B-loaded solid lipid nanoparticles. Appl Biochem Biotechnol 174:1309\u20131330. https:\/\/doi.org\/10.1007\/s12010-014-1084-y","journal-title":"Appl Biochem Biotechnol"},{"key":"594_CR67","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1021\/mp500527x","volume":"12","author":"DR Serrano","year":"2015","unstructured":"Serrano DR, Lalatsa A, Dea-Ayuela MA, Bilbao-Ramos PE, Garrett NL, Moger J et al (2015) Oral particle uptake and organ targeting drives the activity of Amphotericin B nanoparticles. Mol Pharm 12:420\u2013431. https:\/\/doi.org\/10.1021\/mp500527x","journal-title":"Mol Pharm"},{"key":"594_CR68","doi-asserted-by":"publisher","first-page":"99","DOI":"10.2217\/nnm-2016-0325","volume":"12","author":"G Shahnaz","year":"2017","unstructured":"Shahnaz G, Edagwa BJ, McMillan JE, Akhtar S, Raza A, Qureshi N, Yasinzai M, Gendelman HM (2017) Development of mannose-achored thiolated Amphotericin B nanocarriers for treatment of visceral leishmaniasis. Nanomed 12:99\u2013115. https:\/\/doi.org\/10.2217\/nnm-2016-0325","journal-title":"Nanomed"},{"key":"594_CR69","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.ijpddr.2019.09.004","volume":"11","author":"MR Jaafari","year":"2019","unstructured":"Jaafari MR, Hatamipour M, Alavizadeh SH, Abbasi A, Saberi Z, Rafati S, Taslimi Y, Mohammadi AM, Khamesipour A (2019) Development of a topical liposomal formulation of Amphotericin B for the treatment of cutaneous leishmaniasis. Int J Parasitol Drugs Drug Resist 11:156\u2013165. https:\/\/doi.org\/10.1016\/j.ijpddr.2019.09.004","journal-title":"Int J Parasitol Drugs Drug Resist"},{"key":"594_CR70","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1093\/jac\/28.suppl_b.49","volume":"28","author":"RT Proffitt","year":"1991","unstructured":"Proffitt RT, Satorius A, Chiang SM, Sullivan L, Adler-Moore JP (1991) Pharmacology and toxicology of a liposomal formulation of Amphotericin B (AmBisome) in rodents. J Antimicrob Chemother 28:49\u201361. https:\/\/doi.org\/10.1093\/jac\/28.suppl_b.49","journal-title":"J Antimicrob Chemother"},{"key":"594_CR71","doi-asserted-by":"publisher","first-page":"4002","DOI":"10.3390\/molecules25174002","volume":"25","author":"A Riezk","year":"2020","unstructured":"Riezk A, Van Bocxlaer K, Yardley V, Murdan S, Croft SL (2020) Activity of Amphotericin B-loaded chitosan nanoparticles against experimental cutaneous leishmaniasis. Molecules 25:4002. https:\/\/doi.org\/10.3390\/molecules25174002","journal-title":"Molecules"}],"container-title":["Acta Parasitologica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11686-022-00594-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11686-022-00594-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11686-022-00594-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,23]],"date-time":"2022-08-23T14:26:49Z","timestamp":1661264809000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11686-022-00594-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,20]]},"references-count":71,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["594"],"URL":"https:\/\/doi.org\/10.1007\/s11686-022-00594-6","relation":{},"ISSN":["1230-2821","1896-1851"],"issn-type":[{"value":"1230-2821","type":"print"},{"value":"1896-1851","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,20]]},"assertion":[{"value":"12 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}